InvestorsHub Logo

poster44ny

11/23/17 11:01 AM

#10398 RE: rjbluesky #10397

It also says:

"After the approval of the reverse stock split by FINRA, the 9,907,548,954 common shares outstanding as at October 11, 2017 will be adjusted to 16,512,582 post reverse stock split common shares. Also, 1,086,186,666 additional post reverse stock split common shares will be issued to make whole for the shares issued after April 18, 2017, as detailed below."

(85% diluting of the 16.5m)

and

"During the nine months ended September 30, 2017 we did not generate any revenues and we incurred a net loss of $5,997,994 compared to a net loss of $2,654,658 during the same period in 2016. The main reasons were the increase in salaries and compensation due to stock based compensation for the reasons discussed above."


Paying themselves $6m from massive diluting while generating no revenues.

This should tell everyone what degenerates are running this legal stealing.


TorontoNewf

11/23/17 11:48 AM

#10399 RE: rjbluesky #10397

You have to wonder on what public information FE Pharmacy made it's decision on.

A cynic might think that all common minority shareholders were being flushed out of the system by simply rotating management, and wiping out all debt, giving a clean start to the same startup folks.

Nobody is going to pop in millions into a company UNLESS they had reasonable assurance of a major return. If there has been developments on the sales side, should we not know about it?


/end of frustration rant.